Most of the medical device marketing strategy documents I have been handed over the years were not strategies. They were lists of tactics: a new website, a LinkedIn calendar, a trade show budget, a webinar series. Nobody had written down who actually signs the purchase order, what claims the company was legally allowed to make, or why a surgeon would switch from the device they have used for a decade. The tactics were fine. The thinking underneath them was missing.

I have spent 25+ years in marketing, working with everyone from early-stage startups to Fortune 500 brands, and medtech is one of the few categories where getting the strategy wrong is expensive in ways many industries never experience. You can burn a year of runway and a lot of goodwill with a clinical audience before anyone notices the plan was hollow. This guide covers how to build a medical device marketing strategy that fits your sales motion, what it should cost, and how to be honest about whether you need outside help.

Start with your sales motion, not your tactics

The single biggest mistake I see in medtech marketing is treating "medical device" as one category. It is not. A capital equipment company selling a $400,000 imaging system to a hospital system has almost nothing in common, from a marketing standpoint, with a company selling a single-use catheter or a consumer-facing hearing device. Before you pick a channel, you need to name your motion.

Capital equipment

Long sales cycles, committee decisions, and budgets that reset annually. In my experience, marketing here is less about generating leads and more about making the sales team's job possible: clinical evidence packaged for a value analysis committee, total-cost-of-ownership arguments for the CFO, and reference customers who will take a phone call. Demand generation matters, but if your reps walk into a hospital without those three things, no amount of top-of-funnel activity will save the deal.

Disposables and consumables

Here the game is different. You are typically fighting for shelf space against an incumbent, working through distributors or GPO contracts, and trying to make switching feel low-risk. Marketing needs to support the clinical champion inside the account, arm the distributor rep who does not care about your product as much as you do, and make the economics simple enough to fit on one page. Volume and repeat purchase matter more than any single big win.

Patient-facing and over-the-counter devices

If patients or consumers make the buying decision, you are closer to consumer marketing than to traditional medtech, but with regulatory constraints most consumer brands never face. Paid media, retail presence, and reviews drive the business. The trap is copying consumer tactics without the compliance layer. One overreaching claim in a paid ad can create a problem that a consumer packaged goods company would never have to think about.

Once you have named your motion, much of the strategy follows from it: the buyer, the evidence you need, and the channels that work.

Map every buyer in the room

In consumer marketing there is usually one buyer. In medtech there are typically four or five, and they often disagree. A workable medical device marketing strategy names each of them and answers what they care about.

• The clinician. Cares about outcomes, workflow, and whether the device makes their day easier or harder. This is your champion, but in my experience the champion rarely controls the budget.
• The value analysis committee. A cross-functional group that exists in many hospital systems specifically to say no to new products. They want clinical evidence, cost comparison, and a reason the current solution is inadequate.
• Procurement and supply chain. Contract terms, GPO alignment, and standardization. They are not against you. They are against complexity.
• IT and biomedical engineering. For connected devices, integration, cybersecurity posture, and maintenance are often deal-breakers that marketing never addresses.
• The patient. Sometimes a buyer, sometimes an influencer, always the reason the device exists. Even for B2B devices, patient-facing materials help the clinician make the case.

The practical output of this exercise is not a persona deck. It is a short document that says, for each buyer, what they need to believe before they say yes, what evidence supports that belief, and what asset delivers it. If you cannot fill in the evidence column, you have found the real problem, and it is not a marketing problem yet.

Build your claims library before you build your website

This is the section many articles on this topic skip, and it is the one that has saved my clients the most grief. In medical devices, what you can say publicly is governed by your regulatory clearance or approval and your labeling. Promoting a device for uses outside its cleared indications is a serious regulatory risk, and marketing teams that come from other industries often do not know where the lines are.

Before anyone writes a headline, sit down with your regulatory and quality people and build a claims library: a list of statements the company is comfortable making, with the substantiation behind each one. Include the comparative claims you can support, the outcome language you can use, and the words you cannot use at all. Then every piece of marketing, from the homepage to a sales rep's email, draws from that library.

This feels slow. It is far faster than pulling a campaign after launch, and it makes regulatory review a formality instead of a fight. It also forces a useful conversation: if the only claims you can substantiate are weak, your evidence budget needs to come before your marketing budget.

The channels that actually move medtech deals

I am wary of channel lists because they invite people to skip the thinking above. With that caveat, here is what I have seen work, roughly in order of impact for most B2B device companies.

1. Clinical evidence and key opinion leaders. Peer-reviewed data, case series, and respected clinicians willing to speak about your device typically do more than any paid channel. Marketing's job is to package that evidence so it travels: summaries, slide-ready visuals, and reprints that a rep can leave behind.
2. Sales enablement. Objection guides, value analysis committee submission kits, and economic calculators. Unglamorous, and typically the highest return per dollar.
3. Conferences and society meetings. Still where relationships get made in this industry. The mistake is spending on the booth and nothing on the follow-up.
4. Search and content. Clinicians and administrators research online before they ever talk to a rep. Ranking for the clinical problem your device solves, not just your product name, builds trust before the first call.
5. Account-based outreach on LinkedIn and email. When the target list is a few hundred hospital systems, precision beats reach. Coordinate marketing touches with rep activity instead of running them in parallel.
6. Distributor and GPO marketing. If someone else sells your product, they need to be marketed to as much as the end customer does.

Notice what is not high on the list: broad awareness advertising, social media for its own sake, and anything measured in impressions. Those have a place for patient-facing devices. For B2B medtech, they are usually where budgets go to disappear.

What a medical device marketing strategy should cost

Few of the articles I have read on this topic talk about money, so I will. The figures below are ranges I have seen in Texas; every situation is different and your mileage will vary.

A standalone strategy engagement, meaning the buyer mapping, claims library, positioning, and channel plan described above, typically runs somewhere in the low-to-mid five figures when done by an experienced consultant or fractional executive. Larger healthcare agencies often quote well above that. Some of that premium buys real expertise, and some of it buys overhead, so ask what you are actually getting.

Ongoing execution is the bigger number. In my experience, an early-commercial device company that is serious about growth is often spending in the range of a full-time senior marketer's salary or more per year across people and programs, before trade shows. Companies that spend far less usually have a sales team doing marketing's job by hand.

The honest way to think about it is against your sales cycle. If one hospital system contract is worth seven figures over its life, an investment that shortens the cycle or lifts the win rate a few points pays for itself quickly. If you sell a low-cost device with thin margins through distributors, the math is tighter and the strategy needs to be leaner. I lay out how we price this work on our pricing page so you can compare it against whatever else you are considering.

The Texas angle

Texas has a deeper medtech bench than most people outside the state realize, and that changes how you market here.

Houston is home to the Texas Medical Center, which by most accounts is the largest medical complex in the world. If you sell into hospitals, some of your most important reference accounts and key opinion leaders are within a few square miles of each other. Dallas-Fort Worth has a large concentration of hospital systems, device distributors, and corporate healthcare headquarters, plus the airport access that makes it a natural hub for a sales team covering the central United States. Austin brings the software-adjacent side of medtech: connected devices, digital health, and the venture money that funds them. San Antonio has a long military medicine and biomedical research history that many device companies overlook.

Practically, a Texas medical device company can build a credible reference base, recruit clinical advisors, and staff a sales team without leaving the state. So can your competitors. Being local is not a differentiator on its own; knowing which health systems buy through which channels, and who inside them champions new technology, is. That ground truth comes from working in this market for a long time, and it is a big part of why we built TexasCMO here.

Who should own it: in-house, agency, or fractional

I run a fractional CMO practice, so take this section with that in mind. I will still tell you when we are the wrong answer.

Hire a full-time marketing leader if you are past initial commercial traction, have a sales team of more than a handful of reps, and can afford a senior person plus the team they will need. A good full-time VP of Marketing who knows medtech is worth every dollar at that stage. The challenge is that experienced medtech marketing leaders are scarce and expensive, and hiring the wrong one costs a year.

Hire an agency if you already have a strategy and clear direction and simply need hands to execute: a website, a content program, paid media. Agencies are good at production. In my experience, they are less good at telling you that your positioning is wrong, because that conversation does not generate billable hours.

Hire a fractional CMO if you are between those two points: you need senior strategic leadership now, you cannot yet justify or find a full-time executive, and you want someone who will build the plan and then own it. The version of this that works best, in my experience, is a fractional leader backed by an execution team, so the strategy does not sit in a document waiting for someone to act on it. That is how we structure our turn-key engagements, and for companies that already have some marketing staff, we build around the team you have.

When none of the above is the answer: if you do not have clearance yet, if your clinical evidence is thin, or if your sales team cannot articulate why a hospital should switch, marketing spend will not fix it. Put the money into evidence and sales fundamentals first. I would rather tell a founder to call me back in a year than take an engagement I know will not work. You can see the kind of work we have done, and for whom, on our experience page.

Frequently asked questions

How is a medical device marketing strategy different from a go-to-market strategy?

A go-to-market strategy covers everything required to commercialize a device: regulatory pathway, reimbursement, pricing, distribution, sales model, and marketing. A marketing strategy is one component of that, focused on how you create demand and support the sales motion once the commercial model is set. If you do not have a go-to-market plan yet, build that first. Marketing strategy without a defined sales model is guesswork.

How long does it take to build one?

For a company with existing clearance, some customers, and cooperative regulatory and sales teams, a solid strategy typically takes four to eight weeks. Most of that time is interviews and evidence review, not writing. If you are told it can be done in a week from a questionnaire, be skeptical.

Do we need a medtech-specific marketing partner?

You need someone who understands regulated marketing, multi-stakeholder hospital sales, and clinical evidence. That does not have to mean a firm that only does medtech, but it does mean someone who has done it before. Ask any prospective partner how they would handle a claims review and how they would package clinical data for a value analysis committee. If the answers are vague, keep looking.

What should we measure?

For B2B devices: pipeline created and influenced, sales cycle length, win rate by segment, and the number of active clinical champions. For patient-facing devices: customer acquisition cost, repeat purchase, and review sentiment. Website traffic and social followers are inputs, not outcomes, and I would push back on any partner who leads with them.

The next step

If you are a Texas medical device company trying to figure out whether your marketing strategy is a real strategy or a list of tactics, the fastest way to find out is to have someone who has done this look at it. We start every engagement with an audit of what you have, where the gaps are, and what we would do first. If the honest answer is that you do not need us yet, you will hear that too.

Book an audit and we will take it from there.